Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Cory Jubinville's Stock Ratings
LifeSci Capital Analyst
Cory Jubinville is an analyst at LifeSci Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/23/2025
Overall Average Return
6.10%
Smart Score
Overall Average Return Percentile
51st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/18/2025 | VERV | Buy Now | Verve Therapeutics | $11.06 | 8.49% | Cory Jubinville41% | → $12 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/24/2024 | MREO | Buy Now | Mereo BioPharma Group | $2.79 | 258.67% | Cory Jubinville41% | → $10 | Initiates | → Outperform | Get Alert |
| 10/03/2024 | LQDA | Buy Now | Liquidia | $13.58 | 120.93% | Cory Jubinville41% | → $30 | Initiates | → Outperform | Get Alert |
| 02/14/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Cory Jubinville41% | — | Downgrade | Outperform → Market Perform | Get Alert |
